Company Announcement - Polyrizon Ltd appoints Dr Michal Meir as Senior Director of Regulatory and Clinical Affairs as part of preparations for the PL-14 clinical trial expected to commence in 2025 [1] - Dr Meir brings over a decade of experience in medical device and pharmaceutical industries with expertise in regulatory strategy, clinical affairs management and product development [1] Dr Michal Meir's Background - Dr Meir has extensive experience in planning and executing clinical studies that comply with stringent regulatory requirements [2] - She has held leadership roles at Medtech SME Ltd, Keystone Heart and Alma Lasers, successfully navigating complex regulatory landscapes and spearheading clinical initiatives [2] - Notable achievements include managing global regulatory submissions, developing clinical strategies for new medical devices and authoring critical regulatory and clinical documents [3] Company Leadership Commentary - Polyrizon CEO Tomer Izraeli believes Dr Meir's experience will be invaluable in advancing the company's mission to deliver cutting-edge solutions [3] - Her strategic insights and leadership are expected to strengthen capabilities and play an important role in successful product development and approval [3] About Polyrizon - Polyrizon is a development stage biotech company specializing in innovative intranasal hydrogel medical devices [4] - The company's proprietary Capture and Contain (C&C) hydrogel technology forms a thin shield barrier in the nasal cavity to protect against viruses and allergens [4] - C&C technology is delivered via nasal sprays and functions as a "biological mask" with potential for intranasal drug delivery [4] - The company is further developing aspects of C&C technology such as bioadhesion and prolonged retention at nasal deposition sites [4] - Polyrizon is also developing Trap and Target (T&T) technology focused on nasal delivery of active pharmaceutical ingredients (APIs) in pre-clinical stages [4]
Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs